Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions

[1]  S. Morganella,et al.  A Compendium of Mutational Signatures of Environmental Agents , 2019, Cell.

[2]  M. Stratton,et al.  Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis , 2019, Cell.

[3]  E. Cuppen,et al.  The mutational impact of culturing human pluripotent and adult stem cells , 2018, Nature Communications.

[4]  William W. Greenwald,et al.  Insights into the Mutational Burden of Human Induced Pluripotent Stem Cells from an Integrative Multi-Omics Approach. , 2018, Cell reports.

[5]  S. Nik-Zainal,et al.  Validating the concept of mutational signatures with isogenic cell models , 2018, Nature Communications.

[6]  Radhakrishnan Sabarinathan,et al.  Reduced mutation rate in exons due to differential mismatch repair , 2017, Nature Genetics.

[7]  E. Mizutani,et al.  Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation , 2017, Nature.

[8]  K. Eggan,et al.  Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications. , 2017, Stem cell reports.

[9]  Paul Bertone,et al.  Epigenetic resetting of human pluripotency , 2017, Development.

[10]  Lei Zhang,et al.  Differences between germline and somatic mutation rates in humans and mice , 2017, Nature Communications.

[11]  R. Handsaker,et al.  Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations , 2017, Nature.

[12]  Takashi Daimon,et al.  Autologous Induced Stem‐Cell–Derived Retinal Cells for Macular Degeneration: Brief Report , 2017, The New England journal of medicine.

[13]  Miguel A. Juárez,et al.  Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells , 2016, Stem cell reports.

[14]  W. Reik,et al.  Comparative Principles of DNA Methylation Reprogramming during Human and Mouse In Vitro Primordial Germ Cell Specification , 2016, Developmental cell.

[15]  A. Aguilera,et al.  Transcription–replication conflicts: how they occur and how they are resolved , 2016, Nature Reviews Molecular Cell Biology.

[16]  M. Rao,et al.  Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications , 2016, Stem Cell Reviews and Reports.

[17]  A. Bradley,et al.  Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells , 2016, PLoS genetics.

[18]  J. Nichols,et al.  Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass , 2016, Stem cell reports.

[19]  William A. Pastor,et al.  Naive Human Pluripotent Cells Feature a Methylation Landscape Devoid of Blastocyst or Germline Memory. , 2016, Cell stem cell.

[20]  K. Sermon,et al.  Higher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability , 2016, Stem cell reports.

[21]  Kristopher L. Nazor,et al.  Whole-genome mutational burden analysis of three pluripotency induction methods , 2016, Nature Communications.

[22]  Kristopher L. Nazor,et al.  Increased Risk of Genetic and Epigenetic Instability in Human Embryonic Stem Cells Associated with Specific Culture Conditions , 2015, PloS one.

[23]  Julian Gehring,et al.  SomaticSignatures: inferring mutational signatures from single-nucleotide variants , 2014, bioRxiv.

[24]  Daniel Coca,et al.  Time-Lapse Analysis of Human Embryonic Stem Cells Reveals Multiple Bottlenecks Restricting Colony Formation and Their Relief upon Culture Adaptation , 2014, Stem cell reports.

[25]  L. Ruban,et al.  The differential effects of 2% oxygen preconditioning on the subsequent differentiation of mouse and human pluripotent stem cells. , 2014, Stem cells and development.

[26]  C. Spits,et al.  Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL. , 2014, Molecular human reproduction.

[27]  Riitta Lahesmaa,et al.  Continuous Hypoxic Culturing of Human Embryonic Stem Cells Enhances SSEA-3 and MYC Levels , 2013, PloS one.

[28]  W. Reik,et al.  FGF signalling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency , 2013, Clinical Epigenetics.

[29]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[30]  W. Reik,et al.  FGF Signaling Inhibition in ESCs Drives Rapid Genome-wide Demethylation to the Epigenetic Ground State of Pluripotency , 2013, Clinical Epigenetics.

[31]  Jianzhi Zhang,et al.  Genomic evidence for elevated mutation rates in highly expressed genes , 2012, EMBO reports.

[32]  P. Andrews,et al.  Human Embryonic Stem Cells Fail to Activate CHK1 and Commit to Apoptosis in Response to DNA Replication Stress , 2012, Stem cells.

[33]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[34]  K. Eggan,et al.  Erosion of dosage compensation impacts human iPSC disease modeling. , 2012, Cell stem cell.

[35]  Dong Ryul Lee,et al.  Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage , 2011, Nature Biotechnology.

[36]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[37]  Š. Pospíšilová,et al.  Human Embryonic Stem Cells Are Capable of Executing G1/S Checkpoint Activation , 2010, Stem cells.

[38]  Tom Royce,et al.  A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.

[39]  Gurpreet W. Tang,et al.  The Catalogue of Somatic Mutations in Cancer , 2009 .

[40]  M. Peschanski,et al.  Human embryonic stem cells reveal recurrent genomic instability at 20q11.21 , 2008, Nature Biotechnology.

[41]  K. Sermon,et al.  Recurrent chromosomal abnormalities in human embryonic stem cells , 2008, Nature Biotechnology.

[42]  M. Simon,et al.  The role of oxygen availability in embryonic development and stem cell function , 2008, Nature Reviews Molecular Cell Biology.

[43]  C. Mummery,et al.  Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. , 2007, Genome research.

[44]  R. Pedersen,et al.  Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. , 2007, Human molecular genetics.

[45]  S. Nishikawa,et al.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells , 2007, Nature Biotechnology.

[46]  Yue-zhong Wu,et al.  Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. , 2007, Human molecular genetics.

[47]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[48]  A. Simpson,et al.  Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. , 2006, Cloning and stem cells.

[49]  T. Enver,et al.  Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. , 2005, Human molecular genetics.

[50]  J. Stringer,et al.  Embryonic stem cells and somatic cells differ in mutation frequency and type , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Shicai Wang,et al.  COSMIC: the Catalogue Of Somatic Mutations In Cancer , 2018, Nucleic Acids Res..

[52]  M. Mandai,et al.  Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. , 2017, The New England journal of medicine.

[53]  S. Scherer,et al.  Guide to the human genome , 2010 .

[54]  V. Kadirkamanathan,et al.  Modeling the evolution of culture-adapted human embryonic stem cells. , 2010, Stem cell research.

[55]  J. Thomson,et al.  Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells , 2004, Nature Biotechnology.